Injectable PLGA microspheres encapsulating WKYMVM peptide for neovascularization

• DOI: 10.1016/j.actbio.2015.07.033
• Publication Date: 2015-07-26T13:54:07Z
• Authors: Young Hwan Choi; Soon Chul Heo; Yang Woo Kwon; Hwan D. Kim; Seung Hyun L. Kim; Il Ho Jang; Jae Ho Kim; Nathaniel S. Hwang
• Keywords: Male; 0301 basic medicine; Mice, Inbred BALB C; Neovascularization, Physiologic; In Vitro Techniques; Limb Salvage; Microspheres; Hindlimb; Injections; 12. Responsible consumption; Disease Models, Animal; 03 medical and health sciences; Gene Expression Regulation; Cell Movement; Ischemia; Animals; Humans; Emulsions; Lactic Acid; Oligopeptides; Aorta; Polyglycolic Acid; Cell Proliferation

Formyl peptide receptor-2 (FPR-2) is expressed in various cell types, such as phagocytes, fibroblasts, and endothelial cells. FPR-2 has been reported to play a significant role in inflammation and angiogenic response, and synthetic WKYMVm peptide has been identified as a novel peptide agonist for the FPR-2. In this study, we demonstrate that WKYMVm peptides stimulate the angiogenic potential of outgrowth endothelial cells (OECs). Upon WKYMVm peptide exposure, migration and proliferation of OECs were stimulated. WKYMVm effectively stimulated angiogenesis in tube formation assay and aortic ring assay. Furthermore, we fabricated injectable poly (lactide-co-glycolide) (PLGA) microspheres encapsulating WKYMVm peptides, which showed sustained release of cargo molecule. When WKYMVm peptide encapsulated microspheres were injected into the hind limb ischemia model, a single injection of microspheres was as effective as multiple injections of WKYMVm peptide in restoring blood flow from ischemic injury and promoting capillary growth. These results demonstrate that sustained release of WKYMVm peptide from microspheres in the application to ischemic hind limb extended angiogenic stimulation.Formyl peptide receptor (FPR) has been reported to play an important role in inflammation and angiogenic response. A synthetic WKYMVm peptide has been identified as a novel peptide activating the FPR-2 that is expressed in a various cell types, such as phagocytes, fibroblasts, and endothelial cells. In this manuscript we explored a unique property of high-affinity ligand for formyl peptide receptors-2 (FPR-2) (i.e., WKYMVm). WKYMVm-induced activation of FPR2 has been reported to be crucial in host defense and inflammation by activation of phagocytes, monocytes, and lymphocytes. In this study, highlight the efficacy of WKYMVm peptide's role in inducing neovascularization in vivo hind limb ischemia model when the peptide was released from injected PLGA microspheres in sustained manner. Our results demonstrate that sustained release of WKYMVm peptide from microspheres have extended angiogenic stimulation capacity.